Ask question
Ask question
×
Rimantadinum



Rimantadinum 50 mg tablets

INN: Rimantadine

Registration number: R N002605/01

Pharmacotherapeutic group: Antiviral agent

Indications for use:

Prevention and early treatment of influenza A in adults and children over the age of 7.

Presentation:

50 mg tablets. 10 tablets in blister packaging.

1 or 2 blister packs with instructions for use in carton packaging.



Leave a comment